Low plasma vitamin D levels and muscle-related adverse effects in statin users

Israel Medical Association Journal

Volumn 16, Issue 1, 2014, Pages 42-45

  Eisen, Alon ^a   Lev, Eli ^a   Iakobishvilli, Zaza ^a   Porter, Avital ^a   Brosh, David ^a   Hasdai, David ^a   Mager, Aviv ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Creatine phosphokinase; HMG Co A reductase inhibitor; Muscle related adverse effect (MAE); Myalgia; Myopathy; Statin; Vitamin D

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; CREATINE KINASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MUSCULAR DISEASES; MYALGIA; RISK FACTORS; SEX FACTORS; VITAMIN D;

EID: 84893052367     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Joy TR, Hegele RA. Narrative review: Statin-related myopathy. Ann Intern Med 2009; 150: 858-68.
2. Abd TT, Jacobson TA. Statin-induced myopathy: a review and update. Expert Opin Drug Saf 2011; 3: 373-87.
3. Sathasivam S. Statin induced myotoxicity. Eur J Intern Med 2012; 23: 317-24.
4. Tompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003; 289: 1681-90.
5. Gupta A, Tompson PD. Te relationship of vitamin D defciency to statin myopathy. Atherosclerosis 2011; 215: 23-9.
6. Harari M, Dramsdahl E, Shany S, et al. Increased vitamin D serum levels correlate to clinical improvement of rheumatic disease after Dead Sea climatotherapy. IMAJ 2011; 13: 212-15.
7. Plotnikof GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecifc musculoskeletal pain. Mayo Clin Proc 2003; 78: 1463-705.
8. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D defciency: an important common and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-56.
9. Oren Y, Shapira Y, Agmon-Levin N, et al. Vitamin D insufciency in a sunny environment: a demographic and seasonal analysis. IMAJ 2010; 12: 751-6.
10. Ahmed W, Khan N, Glueck CJ, et al. Low serum 25 (OH) vitamin D levels (<32ng/ml) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 2009; 153: 11-16.
11. Casciola-Rosen L, Mammen AL. Myositis autoantibodies. Curr Opin Rheumatol 2012; 24: 602-8.
12. Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 2012; 12: 127-36.
13. Glueck CJ, Budhani SB, Masineni SS, et al. Vitamin D defciency, myositis-myalgia and reversible statin intolerance. Curr Med Res Opin 2011; 27: 1683-90.
14. Kurnik D, Hochman I, Vesterman-Landes J, et al. Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins. Clin Endocrinol (Oxf) 2012; 77: 36-41.
15. Segal E, Felder S, Haim S, et al. Vitamin D defciency in oncology patients - an ignored condition. IMAJ 2012; 14: 607-12.
16. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-8.
17. Scarpini F, Cappellone R, Auteri A, Puccetti L. Role of genetic factors in statin side-efects. Cardiovasc Hematol Disord Drug Targets 2012; 12: 35-43.
18. Arnson Y, Amital H. Is vitamin D a new therapeutic agent in autoinfammatory and pain syndromes? IMAJ 2011; 13: 234-5.
19. Arnson Y, Amital D, Amital H. The diverse world of vitamin D: Does it also modulate pain sensation? IMAJ 2009; 11: 371-2.
20. Arnson Y, Itzhaky D, Mosseri M, et al. Vitamin D inflammatory cytokines and coronary events: a comprehensive review. Clin Rev Allergy Immunol 2013; 45: 236-247.